Mot de passe
Afficher le mot de passe
Mot de passe oublié ?
Devenir membre gratuitement
Devenir membre
Inscription gratuite
Devenir client
Découvrez nos services
Cotations dynamiques 


SynthèseToute l'actualitéReco analystesAutres languesCommuniquésPublications officiellesActualités du secteur
Actualités dans d'autres langues sur AMGEN INC.
15/10Analysis-Deals, data buzz could help biotech shares exit Wall St's 'no man's land'
15/10Deals, data buzz could help biotech shares exit Wall St's 'no man's land'
14/10LUYE PHARMA : Chinese Regulators Accept Luye Pharma's Marketing Authorization for Osteopor..
12/10AMGEN : Working Together to Improve Public Health Outcomes
08/10ADRs Close Higher; Oil Majors Trade Actively
08/10AMGEN : Discover What Fosters Innovation and Drives Change Through Amgen's Innovation2 Ser..
08/10ASTRAZENECA : Gets US FDA's Orphan Drug Designation for Eosinophilic Esophagitis Drug
08/10ASTRAZENECA : Tezepelumab Gets FDA Orphan Designation for Eosinophilic Esophagitis
07/10AMGEN : Announces New LUMAKRAS™ (sotorasib) Combination Data From Phase 1b CodeBreaK..
07/10Amgen Announces New LUMAKRAS™ Combination Data From Phase 1b CodeBreaK 101 Study In Pat..
07/10AMGEN : Working With Neumora Therapeutics to Develop Therapeutics for Brain Diseases
07/10AMGEN : and Neumora Therapeutics Announce Strategic R&D Collaboration to Accelerate Novel ..
07/10Amgen and Neumora Therapeutics Announce Strategic R&D Collaboration to Accelerate Novel..
07/10Neumora announced that it has received $500 million in funding from a group of investor..
05/10Amgen's 'Underappreciated' Inflammation Portfolio Set to Trigger Growth, RBC Capital An..
04/10AMGEN : Presentation on Inflammation Portfolio from EADV
02/10Kyowa Kirin and Amgen Present Positive Late-Breaking Data from Phase 2 Study of KHK4083..
01/10GLOBAL DIVERSITY AWARENESS MONTH : Our Differences Lead to Better Science
29/09AMGEN : To Webcast Investor Call At EADV 2021
29/09CANDID CONVERSATIONS : Amgen Latin Employee Network
29/09AMGEN : U.S. FDA approves AbbVie's migraine prevention drug
29/09AMGEN : U.S. FDA approves AbbVie's migraine prevention drug
27/09AMGEN : Exploring Climate Change and Lung Health
27/09AMGEN : Secures FDA's Approval for Repatha in Heterozygous Familial Hypercholesterolemia
25/09Amgen Announces U.S. Food and Drug Administration Approves Repatha in Pediatric Patient..
25/09AMGEN : FDA Approves Repatha® (evolocumab) In Pediatric Patients Age 10 And Older With Het..
24/09Amplitude Healthcare Acquisition Corporation announced that it has received $100 millio..
23/09BOURSE DE WALL STREET : As smooth as silk
23/09ANALYST RECOMMENDATIONS : Amgen, Apple, AstraZeneca, FedEx, T-Mobile US...
22/09AMGEN : To Present At The 2021 Cantor Global Healthcare Conference
22/09AMGEN : Releases 8th Edition of Biosimilar Trends Report
22/09AMGEN : Investor Presentation September 2021
21/09AMGEN : Margaret Chu-Moyer Honored with Prestigious Portoghese Lectureship
21/09AMGEN : Secures Favorable Ruling in Patent Dispute Against Sandoz, Zydus Over Psoriasis Dr..
21/09AMGEN : Wins Patent Case on Otezla® (apremilast)
20/09AMGEN : Joins International Respiratory Coalition as Founding Member
20/09VERASTEM : Amgen to Evaluate VS-6766, Sotorasib Combo Therapy in Non-Small Cell Lung Cance..
20/09Wall Street Futures Tumble as China's Evergrande Default Risk Weighs on Sentiment
20/09VERASTEM : Health Care
20/09US Futures Fall, China's Evergrande Default Risk Weighs on Sentiment
20/09Top Premarket Gainers
20/09Verastem Oncology and Amgen Partner to Evaluate VS-6766 in Combination with LUMAKRASTM ..
20/09Verastem Oncology in Collaboration Agreement With Amgen
19/09MIRATI THERAPEUTICS : drug combination shrinks tumors in 39% of colon cancer patients in s..
18/09AMGEN : Celebrates 20 Years of Aranesp® (darbepoetin alfa) as a Treatment for Patients Wit..
16/09AMGEN : Diversity, Inclusion and Belonging at Amgen – A Progress Report
16/09AMGEN : Enters Collaboration With Boehringer Ingelheim to Study Drug Combination to Treat ..
16/09AMGEN : Conference Call from ESMO Presentation
16/09AMGEN : Says Colorectal Cancer Drug Combination Safe and Effective in Trial
16/09AMGEN : LUMAKRAS™ (Sotorasib) Combined With Vectibix® (Panitumumab) Showed Encouragi..
16/09Amgen Inc. Announces the First Combination Study Results from the Phase 1B/2 Codebreak ..
16/09China's biotech sector comes of age with big licensing deals, global ambitions
14/09AMGEN : And The Lundquist Institute Announce That Diadem Therapeuctics Will Receive The Fi..
14/09INSIDER BUY : Beigene
14/09Health Canada Approves Amgen's LUMAKRAS™, the First and Only Targeted Treatment for Pat..
13/09AMGEN : To Present At The 2021 Bank of America Merrill Lynch Global Healthcare Conference
13/09AMGEN : To Webcast Investor Call At ESMO 2021
10/09AMGEN : 20 Years Later and the Pain of 9/11 Still Feels Raw
10/09Amgen Lung Cancer Treatment to Be Used by UK National Health Service
10/09UK's NHS Secures Early-Access Deal For Lung Cancer Drug
10/09AMGEN : Lung cancer patients in England to receive Amgen drug that targets a gene mutation
09/09AMGEN : to Present at the 19th Annual Morgan Stanley Global Healthcare Conference
09/09Aktien New York Schluss: Wall Street und Nasdaq weiten Verluste aus
09/09AKTIEN IM FOKUS : Pharmawerte weiter im Abwärtsstrudel - Biden-Pläne belasten
08/09Amgen Announces Results from Two Analyses of the Phase 2 CodeBreaK 100 Clinical Trial E..
08/09AMGEN : Bactiguard Names Former Amgen Executive As CEO
07/09S&P : 500 cierra en baja; grandes tecnológicas impulsan al Nasdaq a récord
07/09US Stocks Start Holiday-Shortened Week Mostly Lower on Delta Variant Concerns; Big Tech..
07/09Big Tech fuels Nasdaq record, S&P 500 dips
07/09AKTIEN IM FOKUS : US-Pharmawerte nach Abstufungen durch Morgan Stanley schwach
07/09Equities Mixed Midday; Yields Advance
07/09AMGEN : Taking Time Off to Honor a Loved One (at Altitudes of 13,000 Feet)
07/09Dow Jones Industrial Average : Borsa Usa in ribasso su timori rallentamento ripresa eco..
1  2  3  4  5  6  7  8  9  10Suiv.
Prochain événement sur AMGEN INC.